Software enables a personal cell analysis system to become a true walk-away cell-based screening system, intelligently automating hours of microplate processing with no user invention
GuavaLink Automation Server software has been developed to automate the processing of multiple microplates on Guava Personal Cell Analysis (PCA) systems.
Intuitive in operation, the ultra-compact Guava PCA-96 and Easycyte systems are said to have set an international benchmark for single cell analysis and counting in the 96-well format.
GuavaLink allows robot scheduling software to control and integrate Guava PCA systems with all physically compatible robotic arms and liquid handling systems - the result streamlined workflow and enhanced productivity.
Using a series of user-defined worklists, the robot scheduling software is able to send commands to the system while instructing the robotic arm to move microplates to and from a Guava PCA system.
This flexible worklist system allows users to interchange and process different cell-based assays within a microplate series.
GuavaLink enables a Guava PCA system to become a true walk-away cell-based screening system, intelligently automating hours of microplate processing with no user invention.
The Guava EasyCyte is a five-parameter system microplate cytometer microplate cytometer that is flexible, highly affordable, and ultra-compact.
Since it requires only a few microlitres of sample volume, it saves precious and expensive cells, reagents, and compounds.
The system is so easy to use, results are generated with less than a day's training.
The Guava PCA-96 offers turnkey operation in an integrated system consisting of the compact Guava PCA-96 instrument, software to automatically analyse and archive data, and optimised reagents.
The Guava PCA-96 system simplifies cell monitoring and screening, only a few microlitres of samples are required for each experiment, saving precious cells and reagents and reducing potentially hazardous biological waste.
With the Guava PCA-96 experiments can be started sooner and finished faster streamlining the entire research and development process, the company says.
Current screening assays available for the Guava PCA-96 and Easycyte systems include cell counting and viability, cell marker expression, cytotoxicity, cell cycle, CD4/CD8 absolute counting and a suite of assays for apoptosis assessment and cell tracking.
Guava Technologies, a privately held biotechnology and medical device company, is a provider of on-demand, easy-to-use single cell analysis systems.
Guava Personal Cell Analysis (PCA) systems, including the Guava PCA, Guava PCA-96 and Guava EasyCyte systems, are described as integrated, fully optimised, micro-capillary cytometry systems with embedded absolute cell counting capability.
Used worldwide by the life sciences, biotechnology, and pharmaceutical industries, as well as clinical testing institutions (outside the United States and Europe), Guava's products have broad applications in scientific research and throughout the drug discovery and lead optimisation process, as well as for cell counting and optimisation of commercial bio-pharmaceutical production.
Guava offers a variety of assays and dedicated software modules for the Guava PCA systems, enhancing the system's overall ease-of-use.
